| |
| |
|
| Insider
Information: |
Tidmarsh George F |
| Relationship: |
Director |
| City: |
Redwood City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
2,455,405 |
|
|
Indirect Shares
|
82,312 |
|
|
| Direct
Value |
$538,047,457 |
|
|
|
Indirect Value
|
$160,402 |
|
|
| Total
Shares |
2,537,717 |
|
|
| Total
Value |
$538,207,859 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
5
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
5
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-5.0
|
0.0
|
| Percentage
Gain/Loss : |
 -86.3%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Molecular Templates, Inc. |
MTEM |
Founder and President,... |
2005-03-11 |
992,219 |
2005-03-11 |
18,216 |
Premium* |
|
|
Spectrum Pharmaceuticals Inc |
SPPI |
CSO and Head of R&D Op... |
2011-01-03 |
40,000 |
2010-07-15 |
0 |
Premium* |
|
|
Anavex Life Sciences Corp |
AVXL |
Executive Director, Di... |
2012-02-09 |
8,000 |
2012-02-09 |
0 |
Premium* |
|
|
La Jolla Pharmaceutical Co |
LJPC |
President, CEO & Secre... |
2019-04-15 |
1,263,895 |
2019-04-15 |
22,000 |
Premium* |
|
|
Odonate Therapeutics Inc |
ODT |
Director |
2019-09-19 |
151,291 |
2019-09-19 |
0 |
Premium* |
|
|
Revelation Biosciences Ord Shs |
REVB |
Director |
2023-12-08 |
0 |
2023-12-08 |
42,096 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REVB |
Revelation Biosciences Or... |
Director |
– • – |
2023-12-08 |
4 |
S |
$0.52 |
$14,438 |
D/D |
(27,771) |
0 |
0 |
- |
|
| REVB |
Revelation Biosciences Or... |
Director |
– • – |
2023-10-16 |
4 |
S |
$0.65 |
$1,199 |
D/D |
(1,845) |
27,771 |
0 |
- |
|
| REVB |
Revelation Biosciences Or... |
Director |
– • – |
2023-10-16 |
4 |
S |
$0.66 |
$7,243 |
I/I |
(10,957) |
42,096 |
0 |
- |
|
| REVB |
Revelation Biosciences Or... |
Director |
– • – |
2023-09-28 |
4 |
S |
$0.69 |
$986 |
I/I |
(1,429) |
42,096 |
0 |
- |
|
| REVB |
Revelation Biosciences Or... |
Director |
– • – |
2023-09-18 |
4 |
S |
$0.74 |
$2,960 |
D/D |
(4,000) |
39,348 |
0 |
- |
|
| REVB |
Revelation Biosciences Or... |
Director |
– • – |
2023-09-15 |
4 |
S |
$0.73 |
$6,935 |
D/D |
(9,500) |
43,348 |
0 |
- |
|
| REVB |
Revelation Biosciences Or... |
Director |
– • – |
2023-09-14 |
4 |
S |
$0.75 |
$9,000 |
D/D |
(12,000) |
52,848 |
0 |
- |
|
| REVB |
Revelation Biosciences Or... |
Director |
– • – |
2023-04-18 |
4 |
B |
$1.16 |
$29,000 |
D/D |
25,000 |
64,848 |
2.39 |
- |
|
| REVB |
Revelation Biosciences Or... |
Director |
– • – |
2023-04-17 |
4 |
B |
$1.16 |
$30,740 |
D/D |
26,500 |
39,848 |
2.39 |
- |
|
| REVB |
Revelation Biosciences Or... |
Director |
– • • |
2022-02-25 |
4 |
B |
$1.60 |
$32,000 |
D/D |
20,000 |
467,156 |
3.92 |
% |
|
| REVB |
Revelation Biosciences Or... |
Director |
– • • |
2022-02-09 |
4 |
B |
$2.55 |
$76,599 |
D/D |
30,000 |
447,156 |
3.92 |
% |
|
| REVB |
Revelation Biosciences Or... |
Director |
– • • |
2022-02-08 |
4 |
B |
$2.54 |
$2,540 |
D/D |
1,000 |
417,156 |
3.84 |
% |
|
| REVB |
Revelation Biosciences Or... |
Director |
– • • |
2022-02-07 |
4 |
B |
$2.61 |
$109,780 |
I/I |
42,100 |
1,523,335 |
2.25 |
% |
|
| REVB |
Revelation Biosciences Or... |
Director |
– • • |
2022-02-04 |
4 |
B |
$2.31 |
$18,256 |
I/I |
7,900 |
1,481,235 |
2.17 |
% |
|
| REVB |
Revelation Biosciences Or... |
Director |
– • • |
2022-02-04 |
4/A |
B |
$2.45 |
$4,900 |
D/D |
2,000 |
416,156 |
3.84 |
- |
|
| REVB |
Revelation Biosciences Or... |
Director |
– • • |
2022-01-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
414,156 |
|
% |
|
| REVB |
Revelation Biosciences Or... |
Director |
– • • |
2022-01-10 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,473,335 |
|
% |
|
| ODT |
Odonate Therapeutics Inc |
Director |
– • – |
2019-09-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
151,291 |
151,291 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
President, CEO & Secretary |
• • – |
2019-04-15 |
4 |
A |
$6.09 |
$12 |
D/D |
2 |
1,263,895 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
President, CEO & Secretary |
• • – |
2019-03-29 |
4 |
A |
$5.47 |
$514 |
D/D |
94 |
1,263,893 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
President, CEO & Secretary |
• • – |
2019-03-15 |
4 |
A |
$6.49 |
$1,266 |
D/D |
195 |
1,263,799 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
President, CEO & Secretary |
• • – |
2019-02-28 |
4 |
A |
$4.85 |
$1,266 |
D/D |
261 |
1,263,604 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
President, CEO & Secretary |
• • – |
2019-02-15 |
4 |
A |
$5.30 |
$1,267 |
D/D |
239 |
1,263,343 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
President, CEO & Secretary |
• • – |
2019-01-31 |
4 |
A |
$5.13 |
$1,262 |
D/D |
246 |
1,284,446 |
0 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
President, CEO & Secretary |
• • – |
2019-01-15 |
4 |
A |
$5.74 |
$5,017 |
D/D |
874 |
1,284,200 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
